NRG3 (extracellular) Blocking Peptide (#BLP-NR115) is the original antigen used for immunization during Anti-NRG3 (extracellular) Antibody (#ANR-115) generation. The blocking peptide binds and ‘blocks’ Anti-NRG3 (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis of mouse (lanes 1 and 3) and rat (lanes 2 and 4) brain membranes:
- Western blot analysis of human MCF-7 breast adenocarcinoma cell lysate (lanes 1 and 3) and human MDA-MB-231 breast adenocarcinoma cell lysate (lanes 2 and 4):
- (C)RFPGHRVPIRASPR, corresponding to amino acid residues 167-180 of mouse Neuregulin-3 (Accession O35181).